Mizuho Securities Downgrades National Health Investors (NHI) to Neutral

May 22, 2020 4:51 AM EDT
Get Alerts NHI Hot Sheet
Price: $67.37 +1.16%

Rating Summary:
    1 Buy, 9 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 26 | New: 45
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Mizuho Securities analyst Omotayo Okusanya downgraded National Health Investors (NYSE: NHI) from Buy to Neutral with a price target of $55.00 (from $60.00).

The analyst comments "We are concerned about NHI's earnings outlook as COVID-19 has spread to secondary/tertiary markets which dominate the NHI portfolio. With 1) more senior housing operators implementing admission bans/restrictions, 2) most states suggesting senior housing will be one of the last businesses to open, and 3) senior housing not materially benefiting from the CARES Act, we are increasingly worried about tenant credit risk at NHI despite solid rent collection rates in April/May. This is of significance at NHI as the two top tenants (33% of total rents) have low rent coverage, and the inability to pay rent by either could drive a major lease restructuring and dividend cut."

For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.

Shares of National Health Investors closed at $53.89 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Downgrades

Related Entities

Earnings